Clinical Trial Update: Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of triptolide wilfordii in new onset HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• triptolide wilfordii (triptolide wilfordii)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: HIV-infection/AIDS | Phase 3 | Status: COMPLETED